Cite
HARVARD Citation
Uchida, Y. et al. (2020). Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Hepatology research. 50 (12), pp. 1355-1364. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Uchida, Y. et al. (2020). Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Hepatology research. 50 (12), pp. 1355-1364. [Online].